5 May 2021
Martine Rothblatt is Chairman & CEO of United Therapeutics, a biotechnology company she started to save the life of one of her daughters. The company offers FDA approved medicines for pulmonary hypertension and neuroblastoma and is working on manufacturing an unlimited supply of transplantable organs.
Dr Rothblatt previously created and led Sirius XM as its Chairman & CEO and launched other satellite systems for navigation and international television broadcasting. In the field of aviation her Sirius XM satellite system enhances safety with real-time digital weather information to pilots in flight nationwide. She also designed the world’s first electric helicopter and piloted it to a Guinness world record for speed, altitude and flight duration.
In the legal arena, Dr Rothblatt led efforts of the transgender community to establish their own health law standards, and of the International Bar Association to protect autonomy rights in genetic information via an international treaty. She also published dozens of scholarly articles and papers on the law of outer space, resulting in her election to the International Institute of Space Law, and represented the radio astronomy community’s scientific research interests before the Federal Communications Commission.
She has Bachelor’s (Communications Studies, SummaCum Laude), JD (Order of the Coif) and MBA degrees from UCLA, which in 2018 awarded her its highest recognition, the UCLA Medal, as well as a Ph.D. in Medical Ethics from the Royal London School of Medicine & Dentistry. Her patented inventions cover aspects of satellite communication, medicinal biochemistry and cognitive software. Dr Rothblatt’s recent books are on xenotransplantation (Your Life or Mine), gender identity (Transgender to Transhuman) and cyberethics (Virtually Human). She occasionally posts on Instagram @transbinary and Twitter @skybiome.
Sir Magdi Yacoub, The Magdi Yacoub Institute, Heart Science Centre, Harefield Hospital, UK
Werner Seeger, PVRI President 2020-22, Justus-Liebig-University Giessen, Germany
Keynote presentation by Dr Martine Rothblatt
15:00-15:40 BST // 10:00-10:40 EDT
Presenter: // Dr Martine Rothblatt, Founder & CEO of United Therapeutics, USA
The presentation will summarise what therapies are currently available for patients who suffer from PH and the technological advances that enable us to develop transplant organs ‘in the lab’ in an attempt to provide patients all over the world with transplant options where currently no transplant registers are available, or there is a very limited supply of suitable organs.
15:40-16:00 BST // 10:40-11:00 EDT
Moderated by Sir Magdi Yacoub & Professor Werner Seeger
Through worldwide collaboration, we can begin to answer the question of a global disease.